Atlas

Form 483

Apozeal Pharmaceuticals Inc. Form 483, 2012-11-21

FDA issued a Form 483 to Apozeal Pharmaceuticals Inc. on 2012-11-21 with 2 public-safe observations.

483· Form 483 issued2 observations

Apozeal Pharmaceuticals Inc. · Levittown, United States · Issued November 21, 2012

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 Nov 2012
21 CFR 211.58

Buildings not maintained in good state of repair

Cited by Anita R Michael

21 Nov 2012
21 CFR 211.192

Extent of discrepancy, failure investigations

Cited by Anita R Michael

Inspected site

APApozeal Pharmaceuticals Inc.Levittown, United States

Inspection team

ARAnita R Michael

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.58Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Book a demoStart a free trial

Full 483 report

Get the verbatim text of all 2 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere